Nature Communications (Jan 2022)

Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2

  • Valeria Garcia-Flores,
  • Roberto Romero,
  • Yi Xu,
  • Kevin R. Theis,
  • Marcia Arenas-Hernandez,
  • Derek Miller,
  • Azam Peyvandipour,
  • Gaurav Bhatti,
  • Jose Galaz,
  • Meyer Gershater,
  • Dustyn Levenson,
  • Errile Pusod,
  • Li Tao,
  • David Kracht,
  • Violetta Florova,
  • Yaozhu Leng,
  • Kenichiro Motomura,
  • Robert Para,
  • Megan Faucett,
  • Chaur-Dong Hsu,
  • Gary Zhang,
  • Adi L. Tarca,
  • Roger Pique-Regi,
  • Nardhy Gomez-Lopez

DOI
https://doi.org/10.1038/s41467-021-27745-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 20

Abstract

Read online

As pregnant women are considered vulnerable to SARSCoV-2 infection, it is important to investigate the actual risks involved. The authors show here that, while a T cell-dominant inflammatory response is observed at the maternal-foetal interface, the virus remains undetectable in the placenta but triggers specific immune responses in the neonatal (umbilical cord blood) circulation.